Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002601)

(Analysis AN004273)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11
hypoxanthine	ME622610	0.51	1.36	2.47	1.23	0.54	1.17	0.55	0.39	0.60	0.74	0.56
IMP	ME622611	0.60	0.91	1.19	1.33	0.71	1.50	1.01	0.55	0.96	1.28	0.84
AICAR	ME622595	1.03	1.12	0.83	1.80	0.56	1.02	1.17	0.74	0.68	0.73	1.42
guanine	ME622609	1.01	0.66	1.01	1.37	0.86	1.34	1.59	0.78	0.47	0.78	1.12
ZMP	ME622627	1.06	1.17	0.99	1.41	0.85	0.85	1.65	0.72	0.66	0.98	0.66
PRPP	ME622619	1.14	0.74	0.44	0.81	0.90	1.27	2.05	1.33	1.02	0.58	1.06
S-AMP	ME622621	1.49	1.27	0.86	0.68	0.83	1.00	1.05	0.71	0.96	1.43	0.82
dTTP	ME622603	1.12	0.71	0.35	1.64	0.85	1.69	0.97	1.13	0.77	1.18	0.98
NADH	ME622614	1.03	1.14	0.01	1.10	1.39	1.00	1.57	1.10	1.05	0.99	1.20
NADPH	ME622616	1.06	0.98	0.01	1.23	1.22	1.19	1.43	1.12	1.06	1.04	1.07
AMP	ME622596	0.98	0.80	0.37	1.41	1.24	0.94	1.47	1.04	1.08	1.14	0.92
UDP-galactose	ME622623	0.93	0.78	0.30	1.40	1.09	1.21	1.59	1.13	1.07	0.98	0.93
GDP-mannose	ME622605	0.92	1.14	0.47	1.28	1.02	1.16	1.34	0.95	0.93	1.04	1.06
dCTP	ME622602	0.90	0.88	0.35	1.22	1.18	1.26	1.32	1.05	1.12	0.93	1.19
ATP	ME622597	1.03	0.95	0.34	1.12	1.10	1.20	1.25	1.11	1.07	1.08	1.15
UTP	ME622625	1.04	0.97	0.28	1.23	1.08	1.28	1.20	1.05	1.06	1.02	1.22
CTP	ME622600	1.00	0.85	0.25	1.28	1.13	1.30	1.27	1.11	1.10	1.00	1.17
GTP	ME622607	0.96	0.93	0.28	1.29	1.06	1.35	1.29	1.07	1.06	1.03	1.11
CDP	ME622598	1.09	0.92	0.42	0.76	1.27	0.87	1.53	1.19	1.12	1.12	1.06
UDP	ME622622	1.13	1.13	0.46	0.76	1.22	0.83	1.44	1.10	1.04	1.13	1.10
GDP	ME622604	1.05	1.17	0.40	0.98	1.08	0.81	1.54	1.12	0.98	1.13	1.09
GMP	ME622606	1.02	1.20	0.66	0.84	1.04	0.77	1.54	0.92	0.98	1.14	1.09
CMP	ME622599	0.95	0.95	1.01	0.69	1.11	0.80	1.29	1.11	0.99	1.04	1.07
UMP	ME622624	0.95	0.94	1.21	0.63	1.15	0.82	1.21	1.06	0.90	0.99	1.01
guanosine	ME622608	0.77	1.16	0.96	1.08	0.90	1.00	1.33	0.87	0.94	1.18	0.83
adenine	ME622592	0.90	1.19	0.80	1.21	1.01	0.90	1.20	0.95	0.94	1.03	1.00
S-adenosylhomocysteine	ME622620	0.82	1.22	0.99	1.24	0.96	1.01	1.27	0.74	0.80	0.95	1.02
5^-methylthioadenosine	ME622612	0.77	0.88	0.84	0.96	1.06	1.25	1.22	1.00	0.90	1.22	1.00
NAD+	ME622613	1.00	0.91	0.72	1.07	1.00	1.14	1.11	1.06	1.03	1.04	1.08
NADP+	ME622615	1.03	0.91	0.70	1.01	0.96	1.17	1.03	1.15	1.04	1.09	1.09
ADP	ME622593	1.03	0.91	0.71	0.81	1.07	1.04	1.24	1.10	1.06	1.08	1.14
dATP	ME622601	1.08	0.89	0.48	0.95	1.10	1.14	1.24	1.19	1.03	1.00	1.22
NMN	ME622618	0.98	1.18	0.79	0.82	1.00	1.42	0.86	1.24	0.91	1.15	0.78
ADP-ribose	ME622594	0.63	0.59	0.63	1.08	1.37	1.40	1.26	1.22	1.20	1.07	0.77
XMP	ME622626	0.91	0.71	1.04	1.39	0.99	1.20	1.01	1.14	0.92	0.98	0.67

Factors:

F1	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Female
F2	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Male
F3	Group:QC-ExternalStandard \| Timepoint:0 hour \| Sex:-
F4	Group:Training \| Timepoint:1 week of training or control time \| Sex:Female
F5	Group:Training \| Timepoint:1 week of training or control time \| Sex:Male
F6	Group:Training \| Timepoint:2 weeks of training \| Sex:Female
F7	Group:Training \| Timepoint:2 weeks of training \| Sex:Male
F8	Group:Training \| Timepoint:4 weeks of training \| Sex:Female
F9	Group:Training \| Timepoint:4 weeks of training \| Sex:Male
F10	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Female
F11	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Male

Data matrix